552331-87-0 Usage
Uses
Used in Pharmaceutical Industry:
7-Bromo-2-methylquinazoline is used as a chemical intermediate for the synthesis of various pharmaceuticals, specifically for the development of antihypertensive and antineoplastic agents. Its unique structure contributes to the creation of new compounds with therapeutic properties, enhancing the range of available treatments for different conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 7-Bromo-2-methylquinazoline is employed as a precursor in the synthesis of compounds with potential applications in pest control and crop protection, thereby contributing to the development of more effective and targeted agrochemicals.
Used in Research and Development:
7-Bromo-2-methylquinazoline is utilized in research and development as a key component in the synthesis of new organic compounds with potential biological activity. Its versatility in chemical reactions allows for the exploration of novel compounds that may exhibit beneficial properties for various applications in the fields of medicine and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 552331-87-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,2,3,3 and 1 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 552331-87:
(8*5)+(7*5)+(6*2)+(5*3)+(4*3)+(3*1)+(2*8)+(1*7)=140
140 % 10 = 0
So 552331-87-0 is a valid CAS Registry Number.
552331-87-0Relevant academic research and scientific papers
Kinase inhibitors
-
, (2008/06/13)
Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are compositions which inhibit protein kinases and methods of inhibiting protein kinases in a patient.
Kinase inhibitors
-
Page/Page column 72, (2010/01/31)
Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are compositions which inhibit protein kinases and methods of inhibiting protein kinases in a patient.
